智通财经APP讯，朝聚眼科(02219)公布，2025年12月23日耗资约32.46万港元回购12万股股份。 ...

格隆汇12月23日丨朝聚眼科(02219.HK)公告，12月23日耗资32.5万港元回购12万股。 ...

图表一：爱尔眼科WINDESG评级 在刚刚公布的格隆汇"金格奖"名单上，爱尔眼科（300015.SZ）同时出现在两个重磅奖项的揭晓时刻：公司获评"年度 ESG先锋奖（大市值）"，董事会秘书吴士君荣获"年度卓越董秘"。 这并非偶然的叠加。在关注企业综合表现的价值评价体系中，这两项荣誉如同一体两面：一面关注企业如何与社会、 环境和谐共生（ESG），另一面看重企业如何与股东、市场保持良好沟通（治理）。当一家公司能在这两个层面均受 到高度认可，往往反映出其运营中蕴含的深层稳健基因与可持续的发展动力。 | 2025年度卓越公司评选榜单 | | | | | | --- | --- | --- | --- | --- | | UCLUB OUTSTANDING COMPA | | | | | | 公司名称 | 公司代码 | 公司名称 | 公司代码 | | | 爱尔眼科 | 300015:SZ | 同程旅行 | 00780.HK | | | 贝壳 | 02423.HK/BEKE.US | 潍柴动力 | 000338.SZ/02338.HK | | | 波司登 | 03998.HK | 中国飞鹤 | 06186.HK | | ...

| | 2025年度卓越公司评选榜单 | | | | --- | --- | --- | --- | | | 度 ESG先 | | | | | UB OUTSTANDING COMP | | | | 公司名称 | 公司代码 | 公司名称 | 公司代码 | | 爱尔眼科 | 300015:SZ | 同程旅行 | 00780.HK | | 贝壳 | 02423.HK/BEKE.US | 潍柴动力 | 000338.SZ/02338.HK | | 波司登 | 03998.HK | 中国飞鹤 | 06186.HK | | 蒙牛乳业 | 02319.HK | 中国建筑国际 | 03311.HK | | 宁德时代 | 300750.SZ/03750.HK | 中国重汽 | 03808.HK | | | 排名不分先后 | | | 在刚刚公布的格隆汇"金格奖"名单上，爱尔眼科（300015.SZ）同时出现在两个重磅奖项的揭晓时刻：公司获评"年度 ESG先锋奖（大市值）"，董事会秘书吴士君荣获"年度卓越董秘"。 这并非偶然的叠加。在关注企业综合表现的价值评价体系中，这两项荣誉如同一体两面：一面关注企业如何与社会、 环境和谐共生 ...

Core Viewpoint - The "Second Beijing-Tianjin-Hebei Eye Health Multidisciplinary Collaborative Academic Forum" was held to promote innovation in ophthalmic diagnosis and treatment technologies, marking the first anniversary of Tianjin Huaxia Eye Hospital, and aims to enhance eye health services in the region [1][3][25] Group 1: Forum Highlights - The forum gathered renowned experts and scholars from the Beijing-Tianjin-Hebei region to discuss cutting-edge ophthalmic technologies and collaborative models [1][3] - The agenda included substantial academic content, focusing on the integration of disciplines and innovative development in ophthalmology [3][5] - The forum emphasized the importance of breaking down disciplinary barriers to create a high-level communication platform for exploring new models of eye health services [5][10] Group 2: Specialized Services - Tianjin Huaxia Eye Hospital announced the establishment of a specialized presbyopia clinic during the forum, responding to the increasing visual health needs of the aging population [10][14] - The hospital received certifications for its presbyopia correction services from leading companies, affirming its capabilities in this area [12][14] - The hospital aims to provide comprehensive, one-stop services for the elderly, including precise assessments and personalized treatment plans [14] Group 3: Academic Discussions - The forum featured in-depth discussions on various topics, including strategies for refractive cataract surgery and the management of ocular surface diseases [16][17][18] - Experts shared the latest research findings and clinical insights, highlighting the significance of interdisciplinary collaboration in addressing complex eye diseases [16][19] - The discussions were structured into multiple sessions, each focusing on different aspects of ophthalmology, showcasing the detailed development of sub-specialties [16][17][18] Group 4: Community Engagement - The hospital has been actively involved in public welfare activities, launching initiatives to provide eye health services to vulnerable groups [19][21] - The establishment of the "Teacher Eye Health Care Base" in collaboration with the Tianjin Hexi District Education Bureau aims to enhance eye health services for educators [19][21] - A new project, "Jincai Boai: Huaxia Brightness Action," was initiated to support retired military personnel and other disadvantaged groups in need of eye health assistance [21] Group 5: Future Outlook - The hospital plans to align its development with national health strategies and continue enhancing its service quality and efficiency [25] - The successful forum marks a new starting point for the hospital, aiming to contribute to the eye health sector's development in North China and beyond [25]

中国经济网北京12月22日讯华厦眼科（301267）(301267.SZ)今日收报18.28元，跌幅1.35%。该股目前处 于破发状态。 华厦眼科首次公开发行股票的发行费用为28,430.75万元，其中保荐及承销费用为23,201.28万元。 2023年7月4日，华厦眼科披露2022年年度权益分派实施公告。以2022年12月31日的总股本56,000.00万股 为基数，向全体股东每10股派发现金红利人民币2.8元(含税)，共计派发现金红利人民币15,680.00万元； 同时，以资本公积向全体股东每10股转增5股，转增股本前公司总股本为56,000.00万股，转增股本后公 司总股本为84,000.00万股。剩余未分配利润全部结转以后年度分配。 华厦眼科于2022年11月7日在深交所创业板上市，发行价格50.88元/股，保荐机构(主承销商)为中国国际 金融股份有限公司，保荐代表人为沈俊、赵冀。 华厦眼科首次公开发行股票募集资金总额为305,280.00万元，扣除发行费用(不含增值税)后，募集资金 净额为276,849.25万元。华厦眼科最终募集资金比原计划多198998.64万元。华厦眼科于2022年10月28日 ...

Group 1 - The 2025 China Economic Media Integration Development Exchange Conference was held in Beijing, focusing on "Digital Intelligence Empowerment and Transformation Efficiency" [1] - Aier Eye Hospital Group was recognized for its "Sustainable Public Welfare" series of reports, which were selected as a typical case of corporate communication for 2025 [3] - The event aimed to highlight exemplary practices in corporate communication, showcasing strategies that can be replicated and promoted for brand building and high-quality development [3] Group 2 - The "Sustainable Public Welfare" series by Aier Eye Hospital reflects the company's response to national strategies such as rural revitalization and health initiatives, marking a significant brand communication effort [3] - Unlike traditional public welfare communication that focuses on single rescue cases, Aier's approach addresses industry pain points and emphasizes a shift from "blood transfusion" to "blood production" in public welfare models [3] - Real stories of individuals like 71-year-old Wen Aihua and 93-year-old Qin Guiyu illustrate the tangible impact of Aier's public welfare initiatives, making the concept of public welfare relatable and emotionally resonant [4][5] Group 3 - Aier Eye Hospital is committed to enhancing grassroots ophthalmology capabilities and creating a sustainable ecosystem for eye health public welfare, ensuring long-term effectiveness of its initiatives [5] - The recognition serves as a catalyst for Aier Eye Hospital to further optimize its sustainable public welfare model, aiming to engage more people in eye health initiatives and spread awareness [5]

Group 1 - The event focused on "eye health and scientific weight management" to enhance the health literacy of scientific workers in line with the Healthy China strategy [1][2] - The event was organized by the People's Daily Jilin Channel, with support from Yinuo Eye Hospital and Gaoshi Medical Technology, aiming to disseminate knowledge on eye care and weight management [2] - The event featured expert lectures on the relationship between obesity and overall health, as well as practical weight management strategies [5] Group 2 - A lecture on eye health was delivered by Professor Wang Jixue, covering common eye diseases and providing targeted daily eye care guidance for scientific workers [8] - The event included interactive sessions where experts addressed questions from attendees, fostering a lively exchange of ideas [8] - Yinuo Eye Hospital conducted free eye examinations for scientific workers, emphasizing their commitment to safeguarding the vision health of this demographic [8]

Group 1: AI and Technological Innovation - Aier Eye Hospital is developing an "AI Digital Eye Hospital" to enhance eye health services through intelligent management and big data reporting for myopia prevention and treatment [2] - Sanofi Biologics is investing heavily in R&D, with expenditures exceeding 360 million yuan in 2023 and 370 million yuan in 2024, employing 879 R&D personnel, which is 18.28% of its total workforce [2][3] - The SinoGPT AI system combined with CGM technology provides continuous glucose monitoring and personalized intervention suggestions, with products available in over 3,800 hospitals and 220,000 pharmacies across China [3] Group 2: Business Environment and Support - Hunan province is enhancing its business environment through various policies and services, which has led to the establishment of 1,926 new companies by returning Hunan merchants, with total investment reaching 542.8 billion yuan [5] - Bosheng Group has expanded its operations globally, establishing a foreign trade ecosystem that includes overseas economic and trade cooperation zones, attracting over 2,200 companies [4] - The "Three Management and Three Non-Management" principle in Hunan's industrial guidance fund has provided comprehensive financial support to companies like Sanofi Biologics, enabling them to focus on innovation [4] Group 3: Strategic Development and Future Plans - Aier Eye Hospital is investing 2 billion yuan to create the "Oriental Eye Valley" industrial park in Changsha, aiming to strengthen the eye care industry chain over the next 8 to 10 years [7] - Sanofi Biologics is set to complete a global R&D center in Changsha with a 500 million yuan investment, focusing on integrating AI and digital technologies for diabetes management [7] - Bosheng Group plans to enhance cross-border channels and market networks while participating in Hunan's integrated domestic and foreign trade pilot projects [8]

"眼睛是感知世界的'心灵之窗',其健康状况直接决定生活质量。"济南市眼科医院(济南市第二人民医院) 眼科特检科主任刘健介绍,定期进行眼科检查,是早发现、早干预眼部问题的关键。 记者 郭蕊 通讯员 郭兆瑞 济南报道 外眼部检查: 快速排查表层眼病 作为眼科检查的"入门项目",外眼部检查主要聚焦眼睑、结膜、角膜等眼前表部位。 "医生通过直观观察和简单器械辅助,就能判断是否存在红肿、分泌物增多、角膜损伤等问题。"刘健介 绍,这项基础检查虽简单,却能快速排查结膜炎、睑缘炎等常见表层眼病,为后续检查打下基础。 OCT检查: 给眼底照个"透视镜" OCT检查即光学相干断层扫描技术,凭借非侵入性优势,成为眼底检查的"利器"。 揪出眼底细微病变 如果说OCT是"局部特写",眼部广域成像,就是眼底的"全景照片"。 通过专业眼底相机,这项检查能一次性拍摄大范围眼底图像,清晰呈现视网膜、视神经、黄斑等关键区域 的整体状况。 "很多眼底疾病早期症状隐匿,广域成像能帮助医生发现肉眼难以察觉的细微病变,是眼底病早期筛查的重 要手段。"刘健补充道。 裂隙灯检查: 眼科检查的"显微镜" 裂隙灯作为眼科的"显微镜",主要用于观察眼前段结构。" ...